LRI: The International Alliance to end leprosy
- Regional Country
- 600.000 € Investment
- 2020-23 Length
We have joined forces with the Leprosy Research Initiative (LRI), an international consortium to improve the diagnosis and research of leprosy and fund initiatives that contribute to these endeavours.
Leprosy is an NTD which has historically generated stigma around people suffering from it. If it is not diagnosed in its initial phase, it can leave permanent marks on the skin, nerves, mucous membrane of the respiratory tract and eyes.
Although it is not an easily transmissible disease, leprosy’s origins and new and more effective treatment to combat it are still being researched today.
In 2013, the Leprosy Research Initiative (LRI) was launched, an initiative of NLR, ALM, DAHW and effect:hope, all of which are partner organisations with the International Federation of Anti-Leprosy Associations (ILEP). In 2020, we joined this consortium to strengthen work to eliminate leprosy from the most impoverished places.
Through LRI, we support projects to combat leprosy on different fronts by:
- Improving its forms of diagnosis.
- Providing assistance for disability associated with the disease.
- Supporting operational research.
- Raising awareness to combat stigma and discrimination.
- Researching its modes of transmission.
By supporting initiatives to fight against leprosy, we will ensure that people suffering from it can participate in the development of their communities and lead a stigma-free life.
Furthermore, we will strengthen research into new diagnosis tests that are faster and more effective; we will help to map out areas and communities in Africa where leprosy is more widespread; and we will design monitoring and follow-up models on the disease to avoid its incidence increasing.
See other projects where we fight Neglected Tropical Diseases
Support for three laboratories researching and detecting NTDs
Medical research is also conducted in African laboratories. We carry forward work conducted by three of the main laboratories in Ghana that detect NTDs.
A clinical trial to reduce the treatment time for the Buruli ulcer by half
After decades combatting the Buruli ulcer, which affects thousands of people in over 33 countries, we are still unaware of its exact mode of transmission. We know it is related to environments with stagnant and unsafe water.
Strengthening the African network of laboratories for Buruli ulcer research
There are currently no unified protocols for detecting Buruli ulcer. Although the WHO sets guidelines for the control of NTDs, many laboratories in Africa do not have standardised protocols for sample collection and subsequent screening and diagnosis of these diseases.
Simultaneous diagnosis of five skin-related neglected tropical diseases (skin NTDs)
Through this initiative, we are contributing to strengthening public health systems, from small aid stations in the remotest villages to health centres in reference-point towns.